In a study on EGFR-specific CAR-T cells for the treatment of NSCLC, researchers constructed EGFR-CAR-T cells using genetic engineering and established a subcutaneous tumor model of NSCLC in NSG mice. This evidence concerns the gene EGFR and non-small cell lung carcinoma.